Abstract-This study was designed to gain additional insight into the mechanism of the slow force response (SFR) 
I n experiments performed on cat papillary muscles, we found that stretch triggered an autocrine/paracrine mechanism that activated the Na ϩ -H ϩ exchange (NHE) and caused intracellular alkalinization. 1 The increase in intracellular pH (pH i ) seemed to be the result of a chain of events involving endogenous angiotensin II (Ang II) and endothelin (ET) in the muscles and activation of the NHE. Those experiments were performed in the nominal absence of bicarbonate, and the possible effect of the autocrine/paracrine mechanism on cardiac mechanics was not analyzed. In a subsequent study 2 on rat trabeculae bathed with a CO 2 /HCO 3 Ϫ -buffered medium, we showed the involvement of the above-mentioned autocrine/paracrine mechanism in the generation of the slow force response (SFR) to stretch. It is worth noting that despite the stretch-induced activation of the NHE, changes in pH i may not be detected in the presence of CO 2 /HCO 3 Ϫ buffer, 3, 4 as in the experiments on rat trabeculae, 2 because of the simultaneous activation of the Na ϩ -independent Cl Ϫ -HCO 3 Ϫ exchanger (AE) by Ang II 5 or ET. 6 It is well-known that stretch of cardiac muscle generates a biphasic force response, with a rapid increase in force that has been attributed to increased myofilament Ca 2ϩ responsiveness and a second slowly-developing phase, the SFR. 2, 7, 8 The SFR was described by Parmley and Chuck 9 in 1973 and constitutes the possible explanation for the Anrep effect. 10 -12 Previous reports showed that neither L-type Ca 2ϩ currents 13 nor the sarcoplasmic reticulum (SR) 8 contribute to the increase in Ca 2ϩ transient during the SFR. What we do know is that blockade of AT 1 or ET A receptors prevents the increase in Ca 2ϩ transient underlying the SFR. 2 Considering these data and the fact that the blockade of the AT 1 or the ET A receptors also prevented the increase in [Na ϩ ] i because of the enhanced activity of the NHE, 2 we tested the notion that the Na ϩ -Ca 2ϩ exchange (NCX) mediates the increase in contractility. NCX is a sarcolemmal transporter that exchanges 3 Na ϩ for each Ca 2ϩ . At resting membrane potential, the exchanger functions in a Na ϩ in -Ca 2ϩ out mode (forward mode); when the membrane is depolarized positive to the exchanger reverse potential, NCX can bring Ca 2ϩ into the cytosol and extrude Na ϩ (reverse mode). Studies on feline ventricular myocytes provided evidence that NCX contributes to contraction by carrying Ca 2ϩ into the cell during the plateau of the action potential. 14 
Materials and Methods
The SFR to an increase in muscle length from 92% to 98% of L max (termed L 92 and L 98 , respectively) was assessed on cat papillary muscles (0.48Ϯ0.04 mm 2 of cross-sectional area), isometrically contracting at a rate of 0.2 Hz. Muscles were superfused with either bicarbonate-or HEPES-buffered solutions; all the experiments were performed at 30°C. Developed force (DF) in control conditions was 2Ϯ0.1 g/mm 2 at L 92 and 3.9Ϯ0.2 at L 98 . Our preparations were stable over 45 minutes or more, as shown in Figure 3D . Possible participation of catecholamines released by the nerve endings was prevented by prazosin plus atenolol (1 mol/L). Changes in [Na ϩ ] i and pH i were monitored by epifluorescence of sodium-binding benzolfuran isophthatlate (SBFI) or BCECF, respectively. The effects of the following experimental maneuvers on SFR development were analyzed: (1) extracellular Na ϩ removal; (2) functional inactivation of vascular and endocardial endothelial cells with Triton X-100 (TX) 16 ; and (3) inhibition of NHE (1 mol/L HOE 642), reverse mode of NCX (5 mol/L KB-R7943), and endothelin-converting enzyme (ECE) (100 mol/L phosphoramidon) activities as well as AT 1 (1 mol/L losartan), ET A (300 nmol/L BQ 123), or nonselective ET-receptor (0.1 or 1 mol/L TAK 044) blockade. The drugs were added to the perfusate 20 minutes before the stretch, and during this period, none of them changed DF by more than 3% to 4%. To avoid cellular Ca 2ϩ overload in nominally Na ϩ -free solutions, Ca 2ϩ concentration was initially reduced to 0.1 mmol/L and then gradually increased until reaching the same DF as in normal extracellular Na ϩ concentration. We allowed DF to reach steady state before stretching the muscles.
An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org. Figure 1A shows the typical biphasic force response to stretch: a first, rapidly occurring increase and a second, gradually developing phase (the SFR). Figure 1B shows the force response to a second stretch on the same muscle (Ϸ30 minutes apart). Figure 1C shows that the overall increase of DF during the SFRs elicited by 2 consecutive stretches reached similar magnitude after 15 minutes (120Ϯ0.6% first stretch versus 119Ϯ1% second stretch, nϭ5, NS) and validates the comparison of consecutive stretches before and after pharmacological interventions, as later presented.
Results

SFR in Cat Myocardium: General Aspects
Experiments were performed to verify that the autocrine/ paracrine mechanism (release of Ang II 3 release of ET 3 activation of the NHE) described in the rat as mediating the SFR 2 is also detected in cat papillary muscles. Figure 2A shows the effect of the NHE inhibition by HOE 642. Although perhaps predictable in light of our previous results in rat, 2 the SFR decreased after the selective blockade of the NHE. Figure 2B shows that the blockade of AT 1 receptors by losartan diminished the SFR. To investigate the involvement of ET, the effect of ET receptor blockade was tested. Figure  2C shows a concentration-dependent attenuation of the SFR in the presence of TAK 044, a nonselective ET receptor blocker. Figure 2D shows that ET A receptor blockade with BQ 123 also caused a significant attenuation of the SFR.
These data agree with our results in rat 2 showing that ET A -receptor blockade cancelled the SFR as well as the increase in Ca 2ϩ after the stretch. The SFR in cat myocardium is then, as in rat, 2 the result of an autocrine-paracrine activation of the NHE by ET. The confirmation of this chain of events leading to the SFR in cat myocardium is important, because the existence of AT 1 receptors or their coupling to regulatory G proteins is controversial in adult rat cardiac myocytes. [17] [18] [19] Role Played by the NCX in the Generation of the SFR To explore the possible contribution of NCX activity, we studied the effect of extracellular Na ϩ deprivation (either replaced by LiCl or N-methyl-D-glucamine) on the SFR to stretch ( Figures 3A and 3B ). DF was maintained under nominally Na ϩ -free conditions at the same level as in normal extracellular Na ϩ by adjusting Ca 2ϩ concentration in the perfusate. After Na ϩ withdrawal, the SFR was cancelled. These results confirm the NCX involvement in the development of the SFR; however, they do not enable us to define whether this effect is mediated by the forward or the reverse mode of exchange. It may be argued that external Na ϩ withdrawal inhibits the NHE, and, in this respect, these results would provide no additional mechanistic insight than that derived from the HOE 642 experiments. However, under Na ϩ -free Li ϩ -replaced conditions, the NHE is still operative (exchanging Li ϩ for H ϩ ) 20 and the SFR was also abolished, arguing in favor of the NCX as the mechanism responsible for the SFR.
Whether the SFR is caused by the NCX operating in forward mode (decreasing Ca 2ϩ efflux) or in reverse mode (increasing Ca 2ϩ influx) was explored next, taking advantage of KB-R7943, a compound described as a selective inhibitor of the reverse mode of the NCX. 21, 22 Figure 3C shows that the SFR is cancelled in the presence of KB-R7943. The compound also abolished the SFR applied either immediately or 15 minutes after the stretch ( Figure 3D ). When KB-R7943 was added at the beginning of the stretch, the development of the SFR was interrupted after Ϸ3 to 5 minutes, whereas the SFR gradually decreased to the level of the initial phase with a t 1/2 of 9.1Ϯ2.5 minutes (nϭ4) when it was added 15 minutes after the stretch.
Satoh et al 23 showed that 5 mol/L of KB-R7943 selectively inhibited the reverse but not the forward mode of NCX in rat cardiomyocytes. It was recently suggested that KB-R7943 inhibition of ET-1-induced positive inotropic effect is attributable to the inhibition of the NCX reverse mode. 24 Because other nonspecific actions of KB-R7943 were also reported, such as prolongation of action potential duration (APD) and inhibition of Na ϩ , L-type Ca 2ϩ , and K ϩ currents that could interfere with the SFR development, 22,23 the effects of KB-R7943 on APD were analyzed in isolated cat ventricular myocytes. In 4 experiments, 5 mol/L KB-R7943 altered neither the resting membrane potential nor the APD during the first 10 minutes after the pharmacological intervention. After 15 minutes, a slight but insignificant shortening of the APD 50 was detected (727Ϯ51 versus 629Ϯ55 ms, NS), whereas there was no change to the APD 90 . The lack of effect of KB-R7943 on APD 90 compared with the Ϸ66% increase reported in rat myocardium, 23 possibly reflecting genuine species-dependent differences. Although APD prolongation may be a confounding factor in the rat, it does not seem to explain the inhibition of the SFR by KB-R7943 in cat myocardium.
Because stretch activates NHE and an increase in pH i would increase DF by increasing myofilament Ca 2ϩ responsiveness, 25 the effect of stretch on pH i was explored. The pH i response varied with the presence or absence of bicarbonate (Figure 4 ). In the nominal absence of bicarbonate, pH i increased, in agreement with our previous results. 1, 2 In the presence of bicarbonate there was no significant change in pH i after stretch, which can be explained by simultaneous Ang II-induced or ET-1-induced activation of one acidifying and one alkalinizing mechanism (NHE and AE). 5, 6 Given the fact that in bicarbonate, the expected alkalinization after NHE activation is blunted, we sought to determine the increase in [Na ϩ ] i as a marker of NHE activity and the cause of the Ca 2ϩ transient increase during the SFR. Figure 5 shows that the SFR was accompanied by an increase in SBFI fluorescence ratios that would correspond to an estimated increase in [Na ϩ ] i of Ϸ6 mmol/L after 10 minutes of stretch. When muscle length was returned to L 92 , there was also a return of [Na ϩ ] i toward baseline levels, with a t 1/2 of 2Ϯ0.5 minutes. In the presence of KB-R7943, the SFR was suppressed, but the increase in [Na ϩ ] i was still present ( Figure 5 ). These results are compatible with the idea that the NCX 
Possible Role of Endothelial Cells on the SFR
The present results and our previous studies in the rat 2 provide evidence that the release and formation of ET is a mandatory step between Ang II and the activation of the NHE, causing the increase in [Na ϩ ] i and the SFR. However, it is not yet clear whether stretch-induced release of ET is attributable to increased cleavage of big ET to ET by its converting enzyme or to augmented release of preformed peptide. Figure 6 shows that ECE inhibition suppressed both the SFR and the rise in [Na ϩ ] i . This finding suggests that Ang II increases the conversion rate of big ET and reinforces the idea that ET itself is the last agonist of the autocrine/paracrine mechanism. Although it was previously demonstrated that Ang II increases prepro ET-1 mRNA levels, 26 a direct Ang II stimulatory effect on ECE activity 27 should also be considered.
To address whether endothelial cells were the source of ET, the endocardial and vascular endothelial cells were functionally inactivated by a 2-step pretreatment with TX, 16 comprising the injection of TX in the coronaries before dissection of the papillary muscles (vascular endothelium inactivation) and flushing the isolated muscles with TX (endocardial endothelium inactivation). Figure 7 shows that after endothelial inactivation the SFR and the increase in [Na ϩ ] i after the stretch both persisted and that both were blocked by phosphoramidon. The increase in [Na ϩ ] i detected after stretch was somewhat higher than in muscles having functional endothelium. We do not have a reasonable explanation for this unexpected finding. Perhaps dysfunctional endothelial cells accumulate Na ϩ or interfere with its measurement or the myocytes accumulate Na ϩ after the TX treatment. In any case, the SFR was present even in muscles with dysfunctional endothelium, and phosphoramidon was able to abolish both the SFR and the increase in [Na ϩ ] i . Therefore, these data suggest that endothelial cells are not the source for ET. However, one should be cautious, because although the efficacy of TX to produce endothelial dysfunction and abolish NO function are well-accepted, 16 the same rationale may not apply for the production and release of ET.
Discussion
The data presented here confirm and extend the previous finding in the rat myocardium that the increase in the Ca 2ϩ transient generating the SFR is the result of an autocrine/ paracrine mechanism. A major novel contribution of this study is to demonstrate the involvement of the NCX as a mechanism responsible for the SFR. This possibility, although suggested, was not proven previously. 2 The experiments showing the suppression of the SFR after external Na ϩ withdrawal strongly suggest that the NCX is required for the development of the SFR. The abolition of the SFR by KB-R7943 would support that NCX operating in the reverse mode is responsible for the SFR. The rise in [Na ϩ ] i consequent to the ET-induced stimulation of NHE activity shifts the thermodynamic balance of the NCX, promoting the reverse mode of exchange or increasing the time during which the NCX operates in its reverse mode. Whether there is also a contribution of a direct ET stimulatory effect on NCX 28 in addition to the increase in [Na ϩ ] i is not clear. However, we should keep in mind that the increase in [Na ϩ ] i is a mandatory step for SFR development.
The question of why the elevation of [Na ϩ ] i is not corrected by the Na ϩ -K ϩ -ATPase activity may be raised. However, we may speculate that, similarly to the Na ϩ pump lag hypothesis for the force-frequency relationship, the greater Na ϩ entry is balanced by increased Na ϩ pump activity but only at the cost of elevated [Na ϩ ] i and, hence, increased Ca 2ϩ entry. In our experiments, the SFR was diminished by the ET A blocker BQ123 and practically abolished by the nonselective ET blocker TAK 044. These findings would be consistent with the involvement of both the ET A and ET B subtype of receptors in the development of the SFR. However, it has been shown previously in rabbit myocardium that the positive inotropic effect of ET-1 is mediated by an ET A2 subtype of receptor that is less sensitive to BQ123 than to TAK 044. 29 Besides stimulating NHE activity, ET is known to have other potentially inotropic effects, such as those derived from its action on L-type Ca 2ϩ or K ϩ currents. However, studies of the effects of ET-1 on L-type Ca 2ϩ or K ϩ currents are conflicting, 30 -33 and in our experiments the development of the SFR was abolished by preventing the rise in [Na ϩ ] i . Evidence regarding a possible relationship between cAMP levels and SFR was recently presented in ferret papillary muscles. 34 An increase in cAMP was detected in the muscles in which the SFR was present, whereas there was no increase in cAMP when the SFR was absent. It is difficult to compare these data with ours. In our study, it was very unusual to have cat papillary muscles that did not develop the SFR after stretch. Furthermore, our previous experiments 1,2 and those described here were performed in the presence of ␣-and ␤-adrenergic receptor blockade to avoid the possible effects of catecholamine release.
In this study, KB-R7943 prevented the SFR despite the increase in [Na ϩ ] i . Although 5 mol/L KB-R7943 inhibits the reverse mode of NCX but not the forward mode in the rat myocardium, 23 we did not confirm that this is the case in cat myocardium. The possibility that KB-R7943 at the concentration used affected to some extent the forward mode of the NCX cannot be completely denied. The increase in [Na ϩ ] i would decrease the forward mode of NCX (Ca 2ϩ out -Na ϩ in ), increasing diastolic Ca 2ϩ and leading to greater Ca 2ϩ sequestration by the SR, which finally would increase Ca 2ϩ transient. Therefore, by inhibiting the forward mode of the NCX, KB-R7943 would be capable of blocking the SFR. This possibility is unlikely, because, first, this compound was previously shown to inhibit mainly the reverse mode of the NCX, acting as a competitive inhibitor with external Ca 2ϩ . 22 Furthermore, we 2 and other investigators 8 have reported the lack of changes in diastolic Ca 2ϩ during SFR development, and the possible role played by the SR in the SFR was recently ruled out. 8 It is interesting that, analyzing the potential contribution of sarcolemmal ion fluxes to SFR development in an ionic model of cardiac myocytes, Bluhm et al 35 found that the SFR could be mimicked by an increase in [Na ϩ ] i that concurred with an increase in Ca 2ϩ entry through the NCX. In any case, the SFR was practically abolished by blocking the NHE and AT 1 or ET A receptors as well as by pharmacological blockade of the NCX in reverse mode.
No changes in DF were detected when KB-R7943 was added 20 minutes before stretching the muscle from L 92 to L 98 , which contrasts with the fade of the SFR when this compound was applied after the onset of the SFR ( Figure  3D ). One possible explanation could be a lack of SFR to stretches performed at lower muscle lengths, ie, from 86% to 92% of L max . However, stretching between these 2 lengths promoted a SFR of similar magnitude (data not shown) to the ones reported here. Other possibilities to be considered are that the SFR could diminish after a certain time or would not be sustained by an increase in the Ca 2ϩ transient because of the reverse mode of the NCX. We do not have a clear explanation for the lack of changes in DF after the addition of KB-R7943 in control conditions.
The fact that the inhibition of the ECE by phosphoramidon prevented the rise in [Na ϩ ] i and the SFR allows us to conclude that the stretch (through AT 1 receptors) enhances the conversion of big ET to ET instead of promoting the release of previously formed and stored ET. ECE was originally described to be expressed on cell membrane with the catalytic site in the extracellular domain. 36 Two ECE isoforms (ECE-1 and ECE-2) can be differentiated by their optimum pH and sensitivity to phosphoramidon (ECE-2 Ϸ250-fold more sensitive than ECE-1). 37 We chose for our study a phosphoramidon concentration that assured complete inhibition of both isoforms 38 ; thus, we cannot distinguish which isoform is involved. Yamazaki et al 39 showed that ET-1 was constitutively released by neonatal rat cardiomyocytes and that ET-1 mRNA levels were increased by stretch. In the same study, the authors proposed that ET and Ang II synergistically mediate the hypertrophic response to stretch. Our present results showing the suppression of the SFR with phosphoramidon as well as with TAK 044 strongly favor the idea that ET alone is the final mediator of the autocrine/paracrine mechanism leading to the SFR, at least in adult myocardium.
The presence of SFR in muscles with vascular and endocardial endothelial cells functionally inactive indicates, despite the limitations of the method, that Ang II and ET are released by cells other than endothelial ones. Ang II and ET can be produced either by myocytes or fibroblasts. We do not have any evidence of which cell type is the source of the peptides. In this regard, two topics merit consideration. First, the SFR can be detected in isolated rat myocytes. 13 Although this finding supports the theory of an autocrine mechanism, we should keep in mind that fibroblasts may contaminate isolated myocyte preparations. 40 Second, the SFR was detected in our previous study on adult rat trabeculae 2 despite the fact that the presence of AT 1 receptors and their coupling to regulatory G proteins have been disputed in adult rat cardiac myocytes. [17] [18] [19] [20] Because acute stretch can stimulate the release of prestored Ang II from myocytes but not from fibroblasts, 41 the alternative of a paracrine pathway may be proposed. Whereas in an autocrine mechanism the myocyte will be the source and the target of Ang II and ET (as schematized in Figure 8 ), in the paracrine mechanism the Ang II released by the myocytes will bind the AT 1 receptors of rat fibroblasts, where they are highly expressed. 42 The activation of AT 1 receptors on fibroblasts will induce the formation or release of ET by these cells. ET, also in a paracrine fashion, will act on the myocytes, rich in ET A receptors, 18 
